Mn Services Vermogensbeheer B.V. Ionis Pharmaceuticals Inc Transaction History

Mn Services Vermogensbeheer B.V.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $1.33 Million - $1.62 Million	-22,500 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$62.09 - $86.14 $1.4 Million - $1.94 Million	22,500 New	22,500 $1.45 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.15B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.